Scientific Advisory Board

The Max Planck Institute is regularly scientifically evaluated in order to ensure the high quality and productivity of its work in the long term. A core component of this evaluation is the independent advisory board, 90% of whose members come from other research institutes, and over half of them are from abroad. The advisory board evaluates the work of the Max Planck Institute every two years. Its members are appointed by the president of the Max Planck Society.


The ongoing evaluation of the institute by the advisory board is complemented by further processes. In particular, this includes the appointment of new scientific members and directors to the Max Planck Institute, as well as the success of the institute in acquiring third party funds and the evaluation of their subprojects in special research areas with neighboring universities.

Current members of the Scientific Advisory Board:
Prof. Dr. Zea Borok Keck School of Medicine
University of Southern California (CA)
Los Angeles, USA
Prof. Dr. Shaun Coughlin Novartis Institutes for Biomedical Research
Cambridge (MA), USA
Prof. Dr. Britta Engelhardt Medizinische Fakultät
Universität Bern
Bern, Switzerland
Prof. Dr. Axel Haverich Klinik für Herz-, Thorax-, Transplantations- und Gefäßchirurgie
Medizinische Hochschule Hannover
Hannover, Germany
Prof. Dr. Brigid L. M. Hogan Department of Cell Biology
Duke University Medical Center
Durham, USA
Prof. Dr. Philip W. Ingham Living Systems Institute
University of Exeter
Exeter, UK
Prof. Dr. Nick Morell Cambridge Cardiovascular
University of Cambridge, Addenbrooke’s Hospital
Cambridge, UK
Prof. Dr. Tatiana Petrova Department of Oncology
University of Lausanne
Epalinges, Switzerland
Prof. Dr. Frédéric Relaix Institut Mondor de Recherche Biomédicale
Université Paris-Est Créteil Val de Marne
Creteil, France
Prof. Dr. Nadia Alicia Rosenthal Australian Regenerative Medicine Institute
Monarch University
Clayton, Vic, Australia
Prof. Dr. Uwe Strähle Institute of Toxicology and Genetics
Karlsruhe Institute of Technology
Eggenstein-Leopoldshafen, Germany
Prof. Dr. Stephen J. Tapscott Fred Hutchinson Cancer Research Center
Seattle, USA
© 2020 Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany